Phase 2 Study of Clofazimine for the Treatment of Pulmonary Mycobacterium Avium Disease
Latest Information Update: 25 Jun 2024
At a glance
- Drugs Clofazimine (Primary)
- Indications Mycobacterium avium complex infections
- Focus Therapeutic Use
- 22 May 2024 Results (n=82) assessing safety data presented at the 120th International Conference of the American Thoracic Society
- 16 Jan 2024 Planned End Date changed from 1 Dec 2024 to 1 Apr 2025.
- 16 Jan 2024 Planned primary completion date changed from 1 Sep 2024 to 1 Dec 2024.